Brian Ladle

Medicine & Life Sciences

1. T-Lymphocytes 100%
2. Ewing's Sarcoma 45%
3. DNA Methylation 36%
4. Pediatrics 35%
5. Sarcoma 35%
6. Cell- and Tissue-Based Therapy 32%
7. 7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile 32%
8. Neoplasms 31%
9. Tumor-Infiltrating Lymphocytes 31%
10. Tertiary Lymphoid Structures 29%
11. DNA methyltransferase 3A 28%
12. Alveolar Soft Part Sarcoma 27%
13. atezolizumab 27%
14. Neoplasm Antigens 26%
15. Chimeric Antigen Receptors 23%
16. Vaccines 23%
17. Progression-Free Survival 22%
18. Neoplasm Metastasis 21%
19. Granulocyte-Macrophage Colony-Stimulating Factor 20%
20. Tumor Microenvironment 20%
21. Gene Fusion 19%
22. Immunosuppressive Agents 18%
23. Osteosarcoma 18%
24. Vaccination 17%
25. Epigenomics 17%
26. T-Cell Antigen Receptor 17%
27. Neuroblastoma 17%
28. Liver Neoplasms 17%
29. Lung 15%
30. Immunity 15%
31. Methyltransferases 15%
32. Immunotherapy 14%
33. Macrophages 14%
34. Young Adult 13%
35. Colorectal Neoplasms 13%
36. Lung Neoplasms 13%
37. Rhabdomyosarcoma 13%
38. Radiation 12%
39. Memory 12%
40. Methylation 12%
41. Antigens 12%
42. Obesity 12%
43. Recurrence 11%
44. Bacteroides fragilis 11%
45. Cyclophosphamide 11%
46. Breast Neoplasms 11%
47. Bone and Bones 10%
48. Cancer Vaccines 10%
49. Testicular Neoplasms 9%
50. Cytokines 9%